BIIB - Biogen Inc
This page shows which of the focused investors we track hold BIIB and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2017 it was held by 4 managers with an aggregate reported value of $23.99M, which is 0.00% of the combined portfolio.
As of Q3 2017, 4 tracked institutional managers held BIIB (Biogen Inc) with an aggregate reported value of $23.99M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BIIB — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2017
- Ticker
- BIIB
13F data is delayed and excludes shorts/non-13F assets.
Long holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.68% | New | 48,000 | $15.03M |
| 2 | Muhlenkamp - Muhlenkamp | 2.55% | Reduce -3.9% | 24,547 | $7.69M |
| 3 | Mairs & Power Growth Fund - Mairs & Power Growth Fund | 0.00% | - | 1,053 | $330K |
Call holders — bullish via leverage
1 manager holds call options on BIIB — a right to buy at strike. Notional value, not premium.
| 1 | Muhlenkamp - Muhlenkamp | - | 3,000 | $939K |
Loading holder history for BIIB…